Researchers from the Australian National University (ANU) have discovered that the cheap and widely used drug, heparin, when inhaled can be a uniquely effective prevention and treatment method for COVID-19. Heparin is currently used to prevent blood from clotting and it is typically administered through an injection. However, early results of an ANU clinical study show that inhaling heparin helps prevent those with COVID-19 from developing lung damage and shows promise in protecting people from getting the virus. The results were collected from trials conducted in American hospitals where researchers monitored the effect inhaled heparin had on patients hospitalized with COVID-19, to determine the drug’s ability to combat the virus and its safety. The study found that after inhaling a course of heparin the breathing and oxygen levels of 70 percent of the subjects improved, along with their symptoms according to the World Health Organization COVID symptoms scale. There were …